Cite

HARVARD Citation

    Mou, H. et al. (2023). CRISPR‐induced exon skipping of β‐catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer. Journal of pathology. 259 (4), pp. 415-427. [Online]. 
  
Back to record